IL6 and systemic lupus erythematosus: This IL-6 hyperproduction was type I IFN-dependent, as pretreating keratinocytes with type I IFN increased their IL-6 production, and type I IFN blockade decreased IL-6 secretion by the lupus patients’ keratinocytes [31].